Financiën Amgen Inc.

Aandelen

AMGN

US0311621009

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 16:58:01 04-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
276,47 ^USD	-0,66%		-1,23%	-3,96%

03/12	Sectorupdate: Gezondheidszorgaandelen dalen dinsdag premarket	MT
03/12	Sectorupdate: Gezondheidszorg	MT

Voorlopige winst- en verliesrekening: Amgen Inc.

income-statement-evolution-chart AMGEN-INC

Fiscaal tijdperk: december	2019	2020	2021	2022	2023	2024	2025	2026
Omzet ¹	23.362	25.424	25.979	26.323	28.190	33.175	34.281	34.930
Variatie	-	8,83%	2,18%	1,32%	7,09%	17,68%	3,34%	1,89%
EBITDA ¹	13.363	15.935	15.822	16.178	17.470	19.059	19.260	19.478
Variatie	-	19,25%	-0,71%	2,25%	7,99%	9,1%	1,06%	1,13%
Bedrijfsresultaat (EBIT) ¹	11.157	12.334	12.424	12.761	13.399	14.785	15.456	15.619
Variatie	-	10,55%	0,73%	2,71%	5%	10,34%	4,54%	1,06%
Betaalde rente ¹	-536	-1.006	-1.197	-1.406	-2.875	-3.142	-2.885	-2.495
Resultaat voor belastingen (EBT) ¹	9.138	8.133	6.701	7.346	7.855	6.688	7.922	8.987
Variatie	-	-11%	-17,61%	9,63%	6,93%	-14,86%	18,45%	13,44%
Nettowinst (verlies) ¹	7.842	7.264	5.893	6.552	6.717	4.883	6.151	7.282
Variatie	-	-7,37%	-18,87%	11,18%	2,52%	-27,31%	25,97%	18,4%
Datum van publicatie	30/01/20	2/02/21	7/02/22	31/01/23	6/02/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: Diciembre	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Omzet ¹	6.197	6.161	6.206	6.423	6.634	5.901	6.526	6.706	6.846	6.238	6.594	6.652	6.839	6.105	6.986	6.903	8.196	7.447	8.388	8.503	8.852	8.082	8.697	8.674	8.972
Variatie	-	-0,58%	0,73%	3,5%	3,29%	-11,05%	10,59%	2,76%	2,09%	-8,88%	5,71%	0,88%	2,81%	-10,73%	14,43%	-1,19%	18,73%	-9,14%	12,64%	1,37%	4,1%	-8,7%	7,6%	-0,26%	3,44%
EBITDA ¹	3.323	4.073	4.177	4.084	3.601	3.705	3.966	4.302	3.849	3.981	4.163	4.114	3.920	3.721	4.411	4.298	5.040	4.477	4.915	5.440	5.146	-	-	-	-
Variatie	-	22,57%	2,55%	-2,23%	-11,83%	2,89%	7,04%	8,47%	-10,53%	3,43%	4,57%	-1,18%	-4,72%	-5,08%	18,54%	-2,56%	17,26%	-11,17%	9,78%	10,68%	-5,41%	-100%	-	-	-
Bedrijfsresultaat (EBIT) ¹	2.621	3.176	3.247	3.183	2.728	2.864	3.111	3.452	2.997	3.140	3.335	3.277	3.009	2.821	3.515	3.403	3.660	3.078	3.873	4.044	3.794	3.525	3.903	3.919	4.069
Variatie	-	21,18%	2,24%	-1,97%	-14,29%	4,99%	8,62%	10,96%	-13,18%	4,77%	6,21%	-1,74%	-8,18%	-6,25%	24,6%	-3,19%	7,55%	-15,9%	25,83%	4,42%	-6,18%	-7,09%	10,74%	0,39%	3,84%
Charge d'intérêts ¹	-65	-335	-293	-247	-131	-285	-281	-296	-335	-295	-328	-368	-415	-543	-419	-759	-821	-824	-808	-776	-722,4	-771	-758,5	-748	-737,5
Resultaat voor belastingen (EBT) ¹	1.983	2.020	2.030	2.206	1.877	1.857	558	2.155	2.131	1.675	1.531	2.392	1.748	3.442	1.614	1.947	852	-68	794	3.101	1.833	-	-	-	-
Variatie	-	1,87%	0,5%	8,67%	-14,91%	-1,07%	-69,95%	286,2%	-1,11%	-21,4%	-8,6%	56,24%	-26,92%	96,91%	-53,11%	20,63%	-56,24%	-	-	290,55%	-40,9%	-100%	-	-	-
Nettowinst (verlies) ¹	1.703	1.825	1.803	2.021	1.615	1.646	464	1.884	1.899	1.476	1.317	2.143	1.616	2.841	1.379	1.730	767	-113	746	2.830	1.039	2.417	2.671	2.704	2.855
Variatie	-	7,16%	-1,21%	12,09%	-20,09%	1,92%	-71,81%	306,03%	0,8%	-22,27%	-10,77%	62,72%	-24,59%	75,8%	-51,46%	25,45%	-55,66%	-	-	279,36%	-63,27%	132,55%	10,51%	1,24%	5,58%
Datum van publicatie	30/01/20	30/04/20	28/07/20	28/10/20	2/02/21	27/04/21	3/08/21	2/11/21	7/02/22	27/04/22	4/08/22	3/11/22	31/01/23	27/04/23	3/08/23	31/10/23	6/02/24	2/05/24	6/08/24	30/10/24	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Amgen Inc.

Fiscaal tijdperk: Diciembre	2019	2020	2021	2022	2023	2024	2025	2026
Nettoschuld ¹	20.992	22.339	25.272	29.640	53.669	48.428	43.375	37.884
Variatie	-	6,42%	13,13%	17,28%	81,07%	-9,77%	-10,43%	-12,66%
Datum van publicatie	30/01/20	2/02/21	7/02/22	31/01/23	6/02/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Amgen Inc.

Fiscaal tijdperk: Diciembre	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	618	608	880	936	1.112	1.292	1.185	1.295
Variatie	-	-1,62%	44,74%	6,36%	18,8%	16,17%	-8,23%	9,28%
Vrije kasstroom (FCF) ¹	8.532	9.889	8.381	8.785	7.359	12.127	11.704	13.179
Variatie	-	15,9%	-15,25%	4,82%	-16,23%	64,8%	-3,49%	12,59%
Datum van publicatie	30/01/20	2/02/21	7/02/22	31/01/23	6/02/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Amgen Inc.

Fiscaal tijdperk: Diciembre	2019	2020	2021	2022	2023	2024	2025	2026
Winstgevendheid
EBITDA-marge (%)	57,2%	62,68%	60,9%	61,46%	61,97%	57,45%	56,18%	55,76%
EBIT-marge (%)	47,76%	48,51%	47,82%	48,48%	47,53%	44,57%	45,09%	44,72%
EBT-marge (%)	39,11%	31,99%	25,79%	27,91%	27,86%	20,16%	23,11%	25,73%
Nettomarge (%)	33,57%	28,57%	22,68%	24,89%	23,83%	14,72%	17,94%	20,85%
FCF-marge (%)	36,52%	38,9%	32,26%	33,37%	26,11%	36,56%	34,14%	37,73%
Vrije kasstroom/nettoresultaat (%)	108,8%	136,14%	142,22%	134,08%	109,56%	248,38%	190,3%	180,97%
Winstgevendheid
ROA	14,32%	15,97%	15,79%	15,16%	12,37%	6,9%	8,46%	9,4%
ROE	81,43%	102,66%	121,63%	184,73%	202,85%	179,97%	149,18%	150,09%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,57x	1,4x	1,6x	1,83x	3,07x	2,54x	2,25x	1,95x
Schuld/vrije kasstroom	2,46x	2,26x	3,02x	3,37x	7,29x	3,99x	3,71x	2,87x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	2,65%	2,39%	3,39%	3,56%	3,94%	3,89%	3,46%	3,71%
CAPEX / EBITDA (%)	4,62%	3,82%	5,56%	5,79%	6,37%	6,78%	6,15%	6,65%
CAPEX / FCF (%)	7,24%	6,15%	10,5%	10,65%	15,11%	10,65%	10,13%	9,83%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	15,02	17,79	16,16	17,97	15,75	18,36	19,85	25,9
Variatie	-	18,41%	-9,16%	11,18%	-12,37%	16,59%	8,12%	30,5%
Dividend per aandeel ¹	5,8	6,4	7,04	7,76	8,52	9,074	9,713	10,26
Variatie	-	10,34%	10%	10,23%	9,79%	6,51%	7,04%	5,63%
Nettoactief per aandeel ¹	16,37	16,28	12,01	6,856	11,65	12,65	14,81	17,76
Variatie	-	-0,54%	-26,24%	-42,9%	69,91%	8,56%	17,15%	19,91%
WPA ¹	12,88	12,31	10,28	12,11	12,49	9,036	11,36	13,99
Variatie	-	-4,43%	-16,49%	17,8%	3,14%	-27,65%	25,67%	23,2%
Aantal aandelen (in duizend)	594.184	582.169	563.266	533.579	535.178	537.533	537.533	537.533
Datum van publicatie	30/01/20	2/02/21	7/02/22	31/01/23	6/02/24	-	-	-